Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) is a publicly traded Healthcare sector company. As of May 21, 2026, RDY trades at $13.63 with a market cap of $11.32B and a P/E ratio of 0.00. RDY moved +1.23% today. Year to date, RDY is -1.37%; over the trailing twelve months it is -6.00%. Its 52-week range spans $12.19 to $16.19. Analyst consensus is sell with an average price target of $0.00. Rallies surfaces RDY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Dr. Reddy’s RDY slides after Q4 profit plunges 86% on weaker sales: Dr. Reddy’s reported Q4 FY26 results today showing an 86% drop in consolidated profit after tax to ₹221.3 crore and an 11.51% revenue decline, driven by weaker North America generics sales. The stock’s drop aligns with investors reacting to the same-day earnings release.
| Metric | Value |
|---|---|
| Price | $13.63 |
| Market Cap | $11.32B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.11% |
| 52-Week High | $16.19 |
| 52-Week Low | $12.19 |
| Volume | 10 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover RDY: 0 strong buy, 0 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $0.00.